#-supreme-cellcarta-differentiators-15-144{items-data:[{"text":"Rich Scientific Expertise "},{"text":"Cutting-edge Technologies"},{"text":"Global Execution "},{"text":"Adaptable Workflows"},{"text":"Integrated Service "}]}#-supreme-cellcarta-faq-13-144{items-data:[{"faq_question":"What is the difference between dPCR and qPCR? ","faq_answer":"dPCR delivers absolute quantification without requiring standard curves,while qPCR provides relative quantities through sample comparison. dPCR uses end-point detection whereas qPCR relies on real-time detection. Amplification efficiency can influence qPCR results but does not affect dPCR. This makes dPCR a more precise and reliable choice for sensitive genomics applications like VCN measurements and pharmacokinetics assays. "},{"faq_question":"What can digital PCR services be used for?","faq_answer":"<p>dPCR applications include RNA expression profiling,low abundant gene quantification,rare event detection,absolute quantification,gene CNV variation,VCN determination,and RCL detection,supporting genomics research,cell therapy,and clinical research programs.</p>"},{"faq_question":"What are the key applications of dPCR for cell therapy?","faq_answer":"<p>dPCR can support adoptive cell therapy (ACT) programs in meeting safety regulations relating to VCN and RCL/RCR levels,even in lymphodepleted samples. For pharmacokinetics (PK) assessment,dPCR is ideal as it detects the smallest changes in VCN,enabling monitoring over a long investigatory period. It can also be employed for biodistribution studies of CAR constructs,where dPCR can accurately detect the accumulation/clearance of lowly concentrated engineered cells.</p>\n<p>Read more about dPCR&rsquo;s applications <a href=\"../../../science-hub/casestudy-act-digitalpcr/\" target=\"_self\">here</a>.</p>"},{"faq_question":"What regulatory bodies do your digital PCR services follow? ","faq_answer":"<p>Our dPCR services conform to the highest degree of quality and are performed in ISO 13485 certified laboratories,allowing for seamless integration into your clinical trial. Read about our full list of accreditations <a href=\"/clinical-trial-services/regulatory-services/cap-clia-iso-accreditations/\" target=\"_self\">here</a>.</p>"}]}#-supreme-cellcarta-featured-resources-16-144{cards-data:[{"image_url":"https://cellcarta.com/wp-content/uploads/2026/07/Cellcarta-Tagline_logo.jpg","image_alt":"","card_type":"Publication ","date":"March 29,2022","reading_time":"","title":"The Digital MIQE Guidelines Update:Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020","description":"","url":"https://pubmed.ncbi.nlm.nih.gov/32746458/","link_target":"_blank"},{"image_url":"https://cellcarta.com/wp-content/uploads/2026/07/Cellcarta-Tagline_logo.jpg","image_alt":"","card_type":"Publication ","date":"Aug 10,2017","reading_time":"","title":"Quality control of digital PCR assays and platforms ","description":"","url":"https://pubmed.ncbi.nlm.nih.gov/28799053/","link_target":"_blank"},{"image_url":"https://cellcarta.com/wp-content/uploads/2026/07/Cellcarta-Tagline_logo.jpg","card_type":"Publication","date":"March 3,2026","reading_time":"","title":"Flexible analysis of digital PCR experiments using generalized linear mixed models - PubMed","description":"","url":"https://pubmed.ncbi.nlm.nih.gov/27551671/","link_target":"_blank"}]}#-supreme-cellcarta-service-blocks-45-176{blocks-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta_-23-2-1-scaled.jpg","image_alt":"","title":"Quantitative PCR (qPCR) ","description":"Cutting-edge technology to understand the transcriptome and its biological context. ","button_text":"Discover","button_url":"/capabilities/genomics/qpcr-services/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Genomic-Data-Analysis-844.jpg","image_alt":"","title":"Genomic Data Analysis ","description":"Comprehensive analysis of all genomic data tailored to your specific project needs.","button_text":"Discover","button_url":"/capabilities/genomics/genomic-data-analysis-services","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Liquid-Biopsy-Platforms-hero-141.jpg","image_alt":"","title":"Liquid Biopsy Platform ","description":"Comprehensive analysis through various platforms,including RareCyte® and TSO500. ","button_text":"Discover","button_url":"/capabilities/genomics/liquid-biopsy-ctc-analysis/","button_target":"_self"}]}#-supreme-cellcarta-tab-content-11-144{tabs-data:[{"tab_title":"OTS & Custom Panels ","content_title":"","content_body":"<p>CellCarta can incorporate OTS assays into your dPCR applications with ease,enabling rapid and robust turnaround times. Key OTS platforms include the QIAGEN Ipsogen dPCR assays.</p>\n<p>When custom primers are required,our team can accommodate the design and validation of primers tailored to your experimental needs. <a href=\"/contact\" target=\"_self\">Contact us</a> regarding any custom developments.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/OTS-Custom-Panels-tab-88.jpg","image_alt":""},{"tab_title":"Key Platforms ","content_title":"","content_body":"<p>Our team offers multiple dPCR platforms to achieve your experimental goals,including Qiagen&rsquo;s QIAcuity and Bio-Rad&rsquo;s QX200TM.</p>\n<p>These platforms can run both OTS and custom panels,as well as handle exploratory assays to support all aspects of your genomic research.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Key-platforms-tab-525.jpg","image_alt":""},{"tab_title":"Standard of Quality ","content_title":"","content_body":"<p>Our global sites are accredited to the highest standards,ensuring our services can meet and scale with your research needs at any stage. All dPCR services are performed in an ISO 13485 accredited environment.</p>\n<p>See our full list of accreditations <a href=\"/clinical-trial-services/regulatory-services/cap-clia-iso-accreditations/\" target=\"_self\">here</a>.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Standard-of-Quality-tab-318.jpg","image_alt":""}]}